---
$id: https://graph.org.ai/products/commodity/51201812
$type: Product
source: UNSPSC
code: "51201812"
title: "Mifamurtide"
class: "51201800"
classTitle: "Immunostimulating agents"
family: "51200000"
familyTitle: "Immunomodulating drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Mifamurtide

**UNSPSC Code**: 51201812
**Class**: [Immunostimulating agents](Immunostimulating agents.mdx)
**Family**: [Immunomodulating drugs](../Immunomodulating drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an immunostimulant with the molecular formula C59H108N6O19P.NA.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1LM890Q4FY. European Medicines Agency schedules mifamurtide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25179. The term MIFAMURTIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21, no. 1, 2007, list 57). Most nations schedule mifamurtide under HS 29329990 and SITC 51569. As of Q4 2014, MIFAMURTIDE remains the US FDA Preferred Term for this commodity. Mifamurtide bears US NLM identifiers UMLS ID C0129341 and NCI Concept Code C1394. SMILES: P(=O)(OCC(OC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCC)(OCCNC(=O)C(NC(=O)CCC(NC(=O)C(NC(=O)C(OC1C(NC(=O)C)C(OC(C1O)CO)O)C)C)C(=O)N)C)O.[NA].O.

